Cullen/Frost Bankers’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-500
| Closed | -$15.3K | – | 1143 |
|
|
2023
Q3 | $15.3K | Hold |
500
| – | – | ﹤0.01% | 888 |
|
|
2023
Q2 | $20K | Hold |
500
| – | – | ﹤0.01% | 856 |
|
|
2023
Q1 | $20.4K | Hold |
500
| – | – | ﹤0.01% | 860 |
|
|
2022
Q4 | $19.3K | Hold |
500
| – | – | ﹤0.01% | 846 |
|
|
2022
Q3 | $27K | Hold |
500
| – | – | ﹤0.01% | 810 |
|
|
2022
Q2 | $29K | Hold |
500
| – | – | ﹤0.01% | 789 |
|
|
2022
Q1 | $38K | Hold |
500
| – | – | ﹤0.01% | 786 |
|
|
2021
Q4 | $30K | Hold |
500
| – | – | ﹤0.01% | 844 |
|
|
2021
Q3 | $28K | Hold |
500
| – | – | ﹤0.01% | 904 |
|
|
2021
Q2 | $30K | Hold |
500
| – | – | ﹤0.01% | 903 |
|
|
2021
Q1 | $35K | Hold |
500
| – | – | ﹤0.01% | 784 |
|
|
2020
Q4 | $30K | Hold |
500
| – | – | ﹤0.01% | 791 |
|
|
2020
Q3 | $30K | Hold |
500
| – | – | ﹤0.01% | 764 |
|
|
2020
Q2 | $26K | Hold |
500
| – | – | ﹤0.01% | 765 |
|
|
2020
Q1 | $17K | Hold |
500
| – | – | ﹤0.01% | 663 |
|
|
2019
Q4 | $23K | Hold |
500
| – | – | ﹤0.01% | 766 |
|
|
2019
Q3 | $19K | Hold |
500
| – | – | ﹤0.01% | 735 |
|
|
2019
Q2 | $22K | Hold |
500
| – | – | ﹤0.01% | 683 |
|
|
2019
Q1 | $19K | Buy |
+500
| New | +$19K | ﹤0.01% | 685 |
|
|
2014
Q4 | – | Sell |
-2,200
| Closed | -$213K | – | 395 |
|
|
2014
Q3 | $213K | Buy |
+2,200
| New | +$213K | 0.01% | 365 |
|